Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

POTUS, Data and How to Increase Your Likelihood of Success

Posted on March 10th, 2016 by

Pharma R&D

success

February 25 marked one year since the advent of the President’s Precision Medicine Initiative and the White House marked the anniversary by hosting a PMI Summit, including a panel discussion in which the POTUS himself Continue reading “POTUS, Data and How to Increase Your Likelihood of Success” »

Catalyzing Decisions in Pharma-Biotech Collaborations

Posted on March 4th, 2016 by

Pharma R&D

collaboration

Despite large strides in technological and scientific progress, the cost to develop and release a new drug has escalated dramatically (1). At the same time, the number of generic drugs has grown in the last decade (2). In the U.S., 70% of Continue reading “Catalyzing Decisions in Pharma-Biotech Collaborations” »

Attack of the Mutants

Posted on March 3rd, 2016 by

Chemistry

lungs, disease

Most parents know how difficult it is to prevent children from taking up bad or unhealthy habits. Children tend to ignore their parents’ advice, convinced as they are that nothing will ever happen to them or their parents are making a fuss about nothing. Continue reading “Attack of the Mutants” »

Validation: The importance of search formulas in Literature Monitoring

Posted on February 29th, 2016 by

Pharmacovigilance

Medical-Literature

A reasonable number of Market Authorization Holders (MAHs) have no ready answer to justify why they use a specific search formula for each specific product when Audit or Inspection time comes: Continue reading “Validation: The importance of search formulas in Literature Monitoring” »

Small Steps with Giant Impact in Pre-Clinical Research

Posted on February 19th, 2016 by

Pharma R&D

APS_HOME_header_dropper

In my last blog entry, I briefly touched up on the various reasons to share your data: it can only make your research better, and help inform the researchers who are doing similar work – or building on what you’ve done. Continue reading “Small Steps with Giant Impact in Pre-Clinical Research” »

Of People with Ideas: Strengthening an ecosystem of innovation

Posted on February 18th, 2016 by

Pharma R&D

reinvention

In the last three decades, the pharmaceutical industry has undergone a transformation unprecedented in the nearly 100-year history of prescription drugs. Continue reading “Of People with Ideas: Strengthening an ecosystem of innovation” »

  1. 1
  2. …
  3. 49
  4. 50
  5. 51
  6. 52
  7. 53
  8. …
  9. 57


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.